structure of 2-Chloro-n-(2-chloroacetyl)-n-(3,4,5-trimethoxyphenyl)acetamide

2-Chloro-n-(2-chloroacetyl)-n-(3,4,5-trimethoxyphenyl)acetamide

CAS No.: 1000932-63-7
M. Wt: 336.1700134
M. Fa: C13H15Cl2NO5
InChI Key: UVJJMADHHHLFOV-UHFFFAOYSA-N

Names and Identifiers of 1000932-63-7

CAS Number

1000932-63-7

MDL Number

MFCD09971387

IUPAC Name

2-chloro-N-(2-chloroacetyl)-N-(3,4,5-trimethoxyphenyl)acetamide

InChI

InChI=1S/C13H15Cl2NO5/c1-19-9-4-8(5-10(20-2)13(9)21-3)16(11(17)6-14)12(18)7-15/h4-5H,6-7H2,1-3H3

InChIKey

UVJJMADHHHLFOV-UHFFFAOYSA-N

Canonical SMILES

COC1=CC(N(C(=O)CCl)C(=O)CCl)=CC(OC)=C1OC

UNSPSC Code

12352100

Physical and chemical properties of 1000932-63-7

H Bond Acceptors

5

H Bond Donors

0

LogP

1.441628315

Molecular Formula

C13H15Cl2NO5

Molecular Weight

336.1700134

Safety Information of 1000932-63-7

Pictograms

Signal Word

Danger

Safety Data Sheet

Supports customized editing of SDS information and downloading in PDF documents.

Applications of 1000932-63-7

Due to its biological activity, this compound has potential applications in:

  • Pharmaceutical research: As a lead compound for developing new drugs targeting UBA5 in cancer therapy.
  • Chemical biology: As a tool for studying ubiquitin-like protein modification pathways.
  • Synthetic chemistry: As an intermediate for synthesizing other complex organic molecules.

Interaction Studies of 1000932-63-7

Interaction studies involving 2-chloro-N-(2-chloroacetyl)-N-(3,4,5-trimethoxyphenyl)acetamide have focused on its binding affinity and inhibitory effects on UBA5. This research aids in understanding the mechanism of action and potential off-target effects. Further studies are necessary to explore its interactions with other proteins involved in cellular signaling pathways.

Biological Activity of 1000932-63-7

Preliminary studies indicate that 2-chloro-N-(2-chloroacetyl)-N-(3,4,5-trimethoxyphenyl)acetamide exhibits significant biological activity. It has been identified as a selective inhibitor of Ubiquitin-like Modifier Activating Enzyme 5 (UBA5), which plays a crucial role in protein modification pathways. The compound demonstrated an IC50 value of approximately 430 μM against UBA5, indicating its potential as a therapeutic agent in cancer treatment, particularly in pancreatic cancer cell lines.